" class="no-js "lang="en-US"> Cardiovascular Archives - Medtech Alert
Tuesday, March 21, 2023

Sort by:

Date

Top Post

New Initiative Aims to Reverse the Alarming Rise in Cardiovascular Deaths

The number of cardiovascular deaths is on the rise again after a decades-long decline. As […]

Acticor Biotech Announces the Enrollment of the First US Patient in Its Phase 2/3 Study ACTISAVE for the Treatment of Stroke

ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT), a clinical-stage biotechnology company developing innovative drugs for the […]

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, today announced the […]

Advanced NanoTherapies' SirPlux Duo Drug-Coated Balloon Receives FDA Breakthrough Designation for Small Vessel Coronary Artery Disease

Advanced NanoTherapies, Inc., a privately-held medical device company committed to solving vascular disease’s most significant […]

Prolifagen Therapeutics Appoints M. Alexander Shaw, PhD, as Chief Executive Officer

Prolifagen Therapeutics, a biotech startup developing medicines for cardiac regeneration, has appointed M. Alexander Shaw, PhD, […]

Cue Health Appoints David Tsay, MD, PhD, as Chief Medical Officer

Cue Health Inc. (“Cue”) ( Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed David […]

Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology

Biosense Webster, Inc., part of Johnson & Johnson MedTech[†], today announced the release of the […]

Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders

Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered […]

Single Pill Proves More Effective at Preventing Further Heart Attack or Stroke

A single pill containing medication to lower cholesterol and blood pressure and stop clotting is […]

Novo Holdings Leads $50 Million Investment in MedGenome to Accelerate Expansion Into New Markets and Deepen Product Offerings

MedGenome, the leading genetic diagnostics, research, and data company in South Asia, announced today a […]

  1. Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Read more
  2. Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) Read more
  3. BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Read more
  4. Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution Read more
  5. GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Read more